Skip to content
Abierto
Menu

Award notice

Xofluza (baloxavir marboxil) 40mg tabs

75A50324F80013

Office of Assistant Secretary for Preparedness and Response, Aspr/Orm-Sns. Pharmaceutical Preparation Manufacturing.

View on SAM.govMarkdown

Awarded

Genentech Usa, Inc.

$21,999,906.94 on the award notice, September 27, 2024, contract 36F79723D0219

Description

As published on SAM.gov.

This requirement is for the supply of Xofluza (baloxavir marboxil) 40mg tablets.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Genentech Usa, Inc.
UEI
SA85BMHCTXK5
CAGE
53VP4
Vendor location
South San Francisco, CA
Contract
75A50324F80013 under 36F79723D0219, delivery order
Obligated
$21,999,906.94
Actions
1 between September 27, 2024 and September 27, 2024
Competition
Full and Open Competition, 1 offer received
Described as
Xofluza (Baloxavir Marboxil)
Match
solicitation number 75A50324F80013 was reused as the contract number; same awarding office 75A503 (high confidence)
Record
USAspending award page
Recipient
Genentech Usa, Inc.
UEI
SA85BMHCTXK5
CAGE
53VP4
Vendor location
South San Francisco, CA
Contract
36F79723D0219
Obligated
$0.00, potential $4,927,972,430
Actions
58 between February 1, 2024 and July 22, 2026
Competition
Full and Open Competition, 999 offers received
Set-aside reported
No Set Aside Used.
Described as
Pharmaceuticals
Match
award number 36F79723D0219 equals the contract number; awarding office not confirmed (medium confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 27, 2024

    Award notice

    Awarded to GENENTECH USA, Inc. South San Francisco for $21,999,907. SAM.gov, notice 2799eb51d6c0432698e0e660cab47acc

Points of contact

Also open from this buyer